← Back to Search

Hydrophilic polymer and potassium ferrate powder for Nail Diseases

Phase 4
Waitlist Available
Led By Shari R Lipner, MD, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial will test a new powder to control bleeding after nail surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study (28 days)
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study (28 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time (in seconds) to bleeding cessation with hydrophilic polymer and potassium ferrate; time (in seconds) to bleeding cessation with direct pressure with sterile gauze
Secondary outcome measures
Number of participants with at least one adverse event

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hydrophilic polymer and potassium ferrate powderExperimental Treatment1 Intervention
Hydrophilic polymer with potassium ferrate powder is applied to the surgical wound with pressure until hemostasis is achieved
Group II: Direct pressure with sterile gauzeActive Control1 Intervention
Direct pressure with sterile gauze is applied to the surgical wound until hemostasis is achieved

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,055 Previous Clinical Trials
1,316,329 Total Patients Enrolled
4 Trials studying Nail Diseases
41 Patients Enrolled for Nail Diseases
Shari R Lipner, MD, PhDPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
10 Total Patients Enrolled
2 Trials studying Nail Diseases
10 Patients Enrolled for Nail Diseases

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery
2022. "Benefit of Topical Hemostatic Powder Containing Hydrophilic Polymer With Potassium Ferrate for Hemostasis Following Nail Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04384679.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top